Ambarish Pandey1, Muthiah Vaduganathan2, Sameer Arora3, Arman Qamar4, Robert J Mentz5, Sanjiv J Shah6, Patricia P Chang3, Stuart D Russell7, Wayne D Rosamond8, Melissa C Caughey9. 1. Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (A.P.). 2. Brigham and Women's Hospital Heart and Vascular Center, Department of Medicine, Harvard Medical School, Boston, MA (M.V.). 3. Division of Cardiology, Department of Medicine (S.A., P.P.C.), University of North Carolina at Chapel Hill, NC. 4. Division of Cardiology, Department of Internal Medicine, New York University School of Medicine (A.Q.). 5. Duke Clinical Research Institute, Durham, NC (R.J.M.). 6. Division of Cardiology, Department of Internal Medicine, Northwestern University School of Medicine, Chicago, IL (S.J.S.). 7. Division of Cardiology, Duke University School of Medicine, Durham, NC (S.D.R.). 8. Department of Epidemiology, Gillings School of Global Public Health (W.D.R.), University of North Carolina at Chapel Hill, NC. 9. Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Chapel Hill (M.C.C.).
Abstract
BACKGROUND: Patients with heart failure (HF) have multiple coexisting comorbidities. The temporal trends in the burden of comorbidities and associated risk of mortality among patients with HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are not well established. METHODS: HF-related hospitalizations were sampled by stratified design from 4 US areas in 2005 to 2014 by the community surveillance component of the ARIC study (Atherosclerosis Risk in Communities). Acute decompensated HF was classified by standardized physician review and a previously validated algorithm. An ejection fraction <50% was considered HFrEF. A total of 15 comorbidities were abstracted from the medical record. Mortality outcomes were ascertained for up to 1-year postadmission by linking hospital records with death files. RESULTS: A total of 5460 hospitalizations (24 937 weighted hospitalizations) classified as acute decompensated HF had available ejection fraction data (53% female, 68% white, 53% HFrEF, 47% HFpEF). The average number of comorbidities was higher for patients with HFpEF versus HFrEF, both for women (5.53 versus 4.94; P<0.0001) and men (5.20 versus 4.82; P<0.0001). There was a significant temporal increase in the overall burden of comorbidities, both for patients with HFpEF (women: 5.17 in 2005-2009 to 5.87 in 2010-2013; men: 4.94 in 2005-2009 and 5.45 in 2010-2013) and HFrEF (women: 4.78 in 2005-2009 to 5.14 in 2010-2013; men: 4.62 in 2005-2009 and 5.06 in 2010-2013; P-trend<0.0001 for all). Higher comorbidity burden was significantly associated with higher adjusted risk of 1-year mortality, with a stronger association noted for HFpEF (hazard ratio [HR] per 1 higher comorbidity, 1.19 [95% CI, 1.14-1.25] versus HFrEF (HR, 1.10 [95% CI, 1.05-1.14]; P for interaction by HF type=0.02). The associated mortality risk per 1 higher comorbidity also increased significantly over time for patients with HFpEF and HFrEF, as well (P for interaction with time=0.002 and 0.02, respectively) Conclusions: The burden of comorbidities among hospitalized patients with acute decompensated HFpEF and HFrEF has increased over time, as has its associated mortality risk. Higher burden of comorbidities is associated with higher risk of mortality, with a stronger association noted among patients with HFpEF versus HFrEF.
BACKGROUND:Patients with heart failure (HF) have multiple coexisting comorbidities. The temporal trends in the burden of comorbidities and associated risk of mortality among patients with HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are not well established. METHODS: HF-related hospitalizations were sampled by stratified design from 4 US areas in 2005 to 2014 by the community surveillance component of the ARIC study (Atherosclerosis Risk in Communities). Acute decompensated HF was classified by standardized physician review and a previously validated algorithm. An ejection fraction <50% was considered HFrEF. A total of 15 comorbidities were abstracted from the medical record. Mortality outcomes were ascertained for up to 1-year postadmission by linking hospital records with death files. RESULTS: A total of 5460 hospitalizations (24 937 weighted hospitalizations) classified as acute decompensated HF had available ejection fraction data (53% female, 68% white, 53% HFrEF, 47% HFpEF). The average number of comorbidities was higher for patients with HFpEF versus HFrEF, both for women (5.53 versus 4.94; P<0.0001) and men (5.20 versus 4.82; P<0.0001). There was a significant temporal increase in the overall burden of comorbidities, both for patients with HFpEF (women: 5.17 in 2005-2009 to 5.87 in 2010-2013; men: 4.94 in 2005-2009 and 5.45 in 2010-2013) and HFrEF (women: 4.78 in 2005-2009 to 5.14 in 2010-2013; men: 4.62 in 2005-2009 and 5.06 in 2010-2013; P-trend<0.0001 for all). Higher comorbidity burden was significantly associated with higher adjusted risk of 1-year mortality, with a stronger association noted for HFpEF (hazard ratio [HR] per 1 higher comorbidity, 1.19 [95% CI, 1.14-1.25] versus HFrEF (HR, 1.10 [95% CI, 1.05-1.14]; P for interaction by HF type=0.02). The associated mortality risk per 1 higher comorbidity also increased significantly over time for patients with HFpEF and HFrEF, as well (P for interaction with time=0.002 and 0.02, respectively) Conclusions: The burden of comorbidities among hospitalized patients with acute decompensated HFpEF and HFrEF has increased over time, as has its associated mortality risk. Higher burden of comorbidities is associated with higher risk of mortality, with a stronger association noted among patients with HFpEF versus HFrEF.
Authors: Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor Journal: J Am Coll Cardiol Date: 2014-11-24 Impact factor: 24.094
Authors: Mohit K Turagam; Jalaj Garg; William Whang; Samantha Sartori; Jacob S Koruth; Marc A Miller; Noelle Langan; Aamir Sofi; Anthony Gomes; Subbarao Choudry; Srinivas R Dukkipati; Vivek Y Reddy Journal: Ann Intern Med Date: 2018-12-25 Impact factor: 25.391
Authors: Ovidiu Chioncel; Mitja Lainscak; Petar M Seferovic; Stefan D Anker; Maria G Crespo-Leiro; Veli-Pekka Harjola; John Parissis; Cecile Laroche; Massimo Francesco Piepoli; Candida Fonseca; Alexandre Mebazaa; Lars Lund; Giuseppe A Ambrosio; Andrew J Coats; Roberto Ferrari; Frank Ruschitzka; Aldo P Maggioni; Gerasimos Filippatos Journal: Eur J Heart Fail Date: 2017-04-06 Impact factor: 15.534
Authors: Johan Sundström; Gustaf Bruze; Johan Ottosson; Claude Marcus; Ingmar Näslund; Martin Neovius Journal: Circulation Date: 2017-03-03 Impact factor: 29.690
Authors: Nathalie Conrad; Andrew Judge; Jenny Tran; Hamid Mohseni; Deborah Hedgecott; Abel Perez Crespillo; Moira Allison; Harry Hemingway; John G Cleland; John J V McMurray; Kazem Rahimi Journal: Lancet Date: 2017-11-21 Impact factor: 79.321
Authors: Melissa C Caughey; Muthiah Vaduganathan; Sameer Arora; Arman Qamar; Robert J Mentz; Patricia P Chang; Clyde W Yancy; Stuart D Russell; Sanjiv J Shah; Wayne D Rosamond; Ambarish Pandey Journal: J Am Geriatr Soc Date: 2021-01-05 Impact factor: 5.562
Authors: Ambarish Pandey; Sanjiv J Shah; Javed Butler; Dean L Kellogg; Gregory D Lewis; Daniel E Forman; Robert J Mentz; Barry A Borlaug; Marc A Simon; Julio A Chirinos; Roger A Fielding; Elena Volpi; Anthony J A Molina; Mark J Haykowsky; Flora Sam; Bret H Goodpaster; Alain G Bertoni; Jamie N Justice; James P White; Jingzhone Ding; Scott L Hummel; Nathan K LeBrasseur; George E Taffet; Iraklis I Pipinos; Dalane Kitzman Journal: J Am Coll Cardiol Date: 2021-09-14 Impact factor: 27.203
Authors: Ravi B Patel; Gregg C Fonarow; Stephen J Greene; Shuaiqi Zhang; Brooke Alhanti; Adam D DeVore; Javed Butler; Paul A Heidenreich; Joanna C Huang; Michelle M Kittleson; Karen E Joynt Maddox; James J McDermott; Anjali Tiku Owens; Pamela N Peterson; Scott D Solomon; Orly Vardeny; Clyde W Yancy; Muthiah Vaduganathan Journal: J Am Coll Cardiol Date: 2021-05-11 Impact factor: 27.203
Authors: Parag Goyal; Brian Yum; Pedram Navid; Ligong Chen; Dae H Kim; Jason Roh; Byron C Jaeger; Emily B Levitan Journal: Am J Cardiol Date: 2021-03-03 Impact factor: 3.133
Authors: P Elliott Miller; Alexander Thomas; Thomas J Breen; Fouad Chouairi; Yukiko Kunitomo; Faisal Aslam; Abdulla A Damluji; Nandan S Anavekar; Joseph G Murphy; Sean van Diepen; Gregory W Barsness; Joseph Brennan; Jacob Jentzer Journal: Am J Med Date: 2020-10-28 Impact factor: 4.965